Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ointment Therapy for Prevention of Cannulation-Induced Phlebitis
NCT04685031Phase 2Unknown
- Sponsor
- Komar University of Science and Technology
- Start
- Feb 2021
- Primary completion
- Apr 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of clobetasol, nitroglycerin in phlebitis, sponsored by Komar University of Science and Technology. Status: unknown.
02
Drugs
clobetasolnitroglycerin
03
Conditions
phlebitis
Beyond the preview
Go deeper on NCT04685031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04685031.